Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y ▼ | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | -4.200% | -8.800% | 8.571% | 198.429% | 99.301% | 137.500% | 156.583% |
| Verastem Inc. | -7.350% | -9.353% | -27.586% | 167.943% | -66.623% | -93.652% | - |
| ImmunityBio Inc. | -0.140% | -0.577% | 0.308% | 132.619% | 24.195% | -51.085% | - |
| Novavax Inc. | -5.970% | -7.143% | -43.038% | 61.495% | 145.733% | -94.088% | 142.609% |
| Esperion Therapeutis.Inc. | 2.330% | 9.568% | 5.470% | 57.542% | -21.394% | -86.937% | -94.486% |
| Ardelyx Inc. | 0.220% | -29.258% | -25.458% | 55.541% | -15.502% | -27.104% | - |
| Evolus Inc | 2.620% | -0.508% | -14.035% | 48.485% | 8.287% | -6.667% | - |
| Geron Corp. | 2.750% | 5.790% | 13.881% | 43.484% | 112.602% | 238.785% | 231.485% |
| Savara Inc. | -1.000% | 4.211% | 2.591% | 37.500% | -8.333% | 197.744% | 66.003% |
| Ocular Therapeutix Inc. | -1.260% | -2.883% | 22.636% | 33.866% | 47.712% | -48.350% | 44.627% |
| Adaptimmune Therapeutics PLC ADR | 13.400% | 22.404% | 16.667% | 28.736% | 79.200% | -69.231% | - |
| G1 Therapeutics | 0.610% | 12.075% | -19.675% | 3.304% | -13.600% | -87.495% | - |
| Puma Biotechnology Inc. | -1.650% | -10.126% | -16.840% | -3.173% | -30.448% | -63.455% | - |
| Cytomx Therapeutics Inc | 1.320% | 5.245% | -21.869% | -27.644% | -13.754% | -77.326% | - |
| Amphastar Pharmaceuticals Inc | -1.200% | -5.279% | -7.869% | -33.252% | -36.796% | - | - |
| Fate Therapeutics Inc. | -0.510% | -4.840% | -15.750% | -35.074% | -18.166% | -96.277% | - |
| Brainstorm Cell | -4.330% | -4.622% | -21.046% | -83.449% | 36.947% | -90.016% | -91.398% |
| Carisma Therapeutics Inc. | -6.830% | -25.662% | -2.112% | -86.245% | -61.095% | -98.619% | -98.156% |